Evidence map›Paper›PMID 28084078›Full record

ArticleAmerican journal of Alzheimer's disease and other dementias2017

Association of GWAS Top Genes With Late-Onset Alzheimer's Disease in Colombian Population.

Diana Jennifer Moreno, Susana Ruiz, Ángela Ríos, Francisco Lopera, Henry Ostos, Marc Via, Gabriel Bedoya

Open access · greenAbstract read
In one paragraph

Article in American journal of Alzheimer's disease and other dementias, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Heterogeneity in Alzheimer's Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Genetic Variants ofFrontiers in neurology · 2019
    Article
  13. Article
  14. Review
  15. Article
  16. Regulation of the Late Onset alzheimer's Disease AssociatedAmerican journal of Alzheimer's disease and other dementias
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Diana Jennifer Moreno1 Grupo de Genética Molecular, Universidad de Antioquia, Medellín, Colombia.
Susana Ruiz1 Grupo de Genética Molecular, Universidad de Antioquia, Medellín, Colombia.
Ángela Ríos2 Grupo de Neuropsicología, Universidad Surcolombiana, Neiva, Colombia.
Francisco Lopera3 Grupo de Neurociencias, Universidad de Antioquia, Medellín, Colombia.
Henry Ostos4 Grupo de Medicina Genómica, Universidad Surcolombiana, Neiva, Colombia.
Marc Via5 Psicologia Clínica i Psicobiologia and Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain.
Gabriel Bedoya1 Grupo de Genética Molecular, Universidad de Antioquia, Medellín, Colombia.
Universidad de Antioquia · COSouth Colombian University · COUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe association of variants in CLU, CR1, PICALM, BIN1, ABCA7, and CD33 genes with late-onset Alzheimer's disease (LOAD) was evaluated and confirmed through genome-wide association study. However, it is unknown whether these associations can be replicated in admixed populations.

methodsThe association of 14 single-nucleotide polymorphisms in those genes was evaluated in 280 LOAD cases and 357 controls from the Colombian population.

resultsIn a multivariate analysis using age, gender, APOE∊4 status, and admixture covariates, significant associations were obtained ( P < .05) for variants in BIN1 (rs744373, odds ratio [OR]: 1.42), CLU (rs11136000, OR: 0.66), PICALM (rs541458, OR: 0.69), ABCA7 (rs3764650, OR: 1.7), and CD33 (rs3865444, OR: 1.12). Likewise, a significant interaction effect was observed between CLU and CR1 variants with APOE.

conclusionThis study replicated the associations previously reported in populations of European ancestry and shows that APOE variants have a regulatory role on the effect that variants in other loci have on LOAD, reflecting the importance of gene-gene interactions in the etiology of neurodegenerative diseases.

Indexed as

Genome-Wide Association StudyAgedAged, 80 and overAge of OnsetAlzheimer DiseaseApolipoprotein E4ColombiaFemaleHumansMalePolymorphism, Single NucleotideApolipoprotein E4APOE∊4genetic admixturegenetic interactionGWASpolymorphismssusceptibility to late-onset Alzheimer’s disease

Identifiers

PMID28084078
PMCPMC10857032
OpenAlexW2575094963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.